Radiation after surgery for early-stage oral tongue cancer
Part of Cancer clinical trials.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You had surgery to remove all visible oral tongue cancer
- Your cancer was early stage (pT1-2 or pT3 by depth) with certain risk factors like lymphovascular invasion or depth between 4 and 10 mm
- Your final surgical report shows clear margins (at least 2.2 to 3 mm, depending on growth pattern)
- You have no more than 2 lymph nodes with cancer and no spread outside the lymph node capsule
- You do not have any other active cancer or autoimmune disease that would interfere with radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding radiation therapy after surgery helps prevent the return of early-stage tongue cancer in patients who have certain risk factors, such as nerve invasion or poorly differentiated cells. It is for people whose cancer was limited to the front two-thirds of the tongue and was completely removed.
This trial tests a new radiation technique combined with chemotherapy and immunotherapy for patients with mouth cancer that has not spread. It aims to improve treatment effectiveness for larger tumors.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
This trial compares two approaches after initial treatment: radiation therapy versus an immunotherapy drug (PD-1 inhibitor) to see which better prevents cancer from coming back. It is for people with advanced oral or throat cancer who have already completed chemoimmunotherapy and surgery to remove all visible cancer.
This trial studies giving chemotherapy first, then removing the tumor with surgery and follow-up radiation for certain cases of oral squamous cell carcinoma. It may help shrink and control the cancer before and after surgery, depending on how well the tumor can be fully removed.
This Phase 2 study tests whether changing the “radiation volume” (how much area is treated) can better preserve swallowing after surgery for oral cavity squamous cell cancer. It may help reduce swallowing problems while still treating the cancer safely.
Hear when a new Oral Tongue Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.